Author Question: At the end of the plateau phase, vasocongestion in the pelvis creates a(n) ____. a. detumescence ... (Read 52 times)

Capo

  • Hero Member
  • *****
  • Posts: 545
At the end of the plateau phase, vasocongestion in the pelvis creates a(n) ____.
 
  a. detumescence c. orgasmic platform
  b. resolution d. tenting effect

Question 2

The Daubert decision listed four factors that judges should consider in assessing the validity and subsequent admissibility of the expert's testimony. Which of the following is not one of these four factors?
 
  A. whether the expert's theory or technique can and has been tested
  B. the strength of the argument for the pertinent side
  C. whether the expert's theory or technique has been evaluated by peer review
  D. the extent to which the expert's technique and claims have been generally accepted by the relevant scientific community



l.stuut

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

C

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

People often find it difficult to accept the idea that bacteria can be beneficial and improve health. Lactic acid bacteria are good, and when eaten, these bacteria improve health and increase longevity. These bacteria included in foods such as yogurt.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library